#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Progressive familial intrahepatic cholestasis Hidradenitis Langerhans' cell histiocytosis Amyotrophic lateral sclerosis gene carrier Endometrial cancer Chondrosarcoma Adrenogenital syndrome Pulmonary arterial hypertension Metastatic gastric cancer Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome B-cell small lymphocytic lymphoma refractory Renal transplant Leukocyte adhesion deficiency type I Deafness Hereditary motor and sensory neuropathy More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Treatment Chordoma – Treatment Mantle cell lymphoma stage III Hereditary optic atrophy – Diagnostics Idiopathic pulmonary fibrosis – Treatment Rhabdomyosarcoma – Trials in Disease Chondrosarcoma metastatic – Life with Disease Turner’s syndrome – Basic Information Encephalitis autoimmune – Diagnostics Mucopolysaccharidosis III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MZE829 LY3848575 Atomoxetine Hydrochloride LY3372993 Corylus Avellana L. GSKVX000000070248 Antithrombin Iii Human Doxorubicin Hydrochloride Amisulpride Sodium Picosulfate Phenol ABY-271 Hct116-B Anhydrous Benzoyl Peroxide [14C]ZIPALERTINIB Cobimetinib Nintedanib Deferoxamine Mesilate AB521 Dfv890 More therapies…

    Learn about Your Condition

    Hereditary angioedema Retroperitoneal cancer Laryngeal cancer stage I Lichen planus Bacteraemia Colorectal cancer stage III Neonatal asphyxia Angiosarcoma non-metastatic Adenomatous polyposis coli Cervical dysplasia Genital herpes simplex Lung neoplasm malignant Cytomegalovirus infection Neurogenic bladder Dystonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Contraception study in women: comparing oral drospirenone‑only, drospirenone + ethinylestradiol, and drospirenone + estetrol tablets

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • DROSPIRENONE
    • Ethinylestradiol
    Finland

  • Effect of cladribine tablets on immune synapse in patients with relapsing multiple sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cladribine
    Greece

  • Safety, tolerability and efficacy of topical human fibroblasts in patients with chronic refractory wounds (two-part study)

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • HUMAN FIBROBLASTS
    Italy

  • Effect of Dexmedetomidine vs Sodium Chloride on Emergence Delirium in Children Aged 1‑7 Years Undergoing Adenotonsillectomy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Anaesthetic complication neurological
    Investigated Drugs:
    • Dexmedetomidine
    • Sodium Chloride
    Norway

  • A Phase 3 Study Evaluating the Efficacy and Safety of Subcutaneous Nomlabofusp in Adults and Children with Friedreich’s Ataxia

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Friedreich’s ataxia
    France

  • Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Phleum Pratense
    • Sodium Chloride
    Spain
Previous Page
1 … 721 722 723 724 725 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!